Clinical Trial Update: Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MC2-25 Cream with a vehicle comparator in women with Vulvar Lichen Sclerosus completed, with reported efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Lichen Sclerosus

Drugs mentioned

• MC2-25 Cream (MC2-25)
• Vehicle (placebo)

Snippet

Sponsor: MC2 Therapeutics | Conditions: Vulvar Lichen Sclerosus | Phase 2 | Status: COMPLETED | Results posted: 2025-10-15